Stocktoria

Zoetis Inc. ZTS

NYSE · stock · Pharmaceutical Preparations · website · IPO 2013-02-01 · LEI

Zoetis Inc. financials (annual)

Revenue
$4.89B $5.31B $5.83B $6.26B $6.67B $7.78B $8.08B $8.54B $9.26B $9.47B 2016201720182019202020212022202320242025
Net income
$821.0M $864.0M $1.43B $1.50B $1.64B $2.04B $2.11B $2.34B $2.49B $2.67B 2016201720182019202020212022202320242025
Free cash flow
$497.0M $1.12B $1.45B $1.33B $1.67B $1.74B $1.33B $1.62B $2.30B $2.28B 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$9.5B$9.3B$8.5B$8.1B$7.8B$6.7B$6.3B$5.8B$5.3B$4.9B
SG&A expense$2.4B$2.3B$2.2B$2.0B$2.0B$1.7B$1.6B$1.5B$1.3B$1.4B
Interest expense$222.0M$225.0M$239.0M$221.0M$224.0M$231.0M$223.0M$206.0M$175.0M$166.0M
Income tax$687.0M$637.0M$596.0M$545.0M$454.0M$360.0M$301.0M$266.0M$663.0M$409.0M
Net income$2.7B$2.5B$2.3B$2.1B$2.0B$1.6B$1.5B$1.4B$864.0M$821.0M
EPS (diluted)$6.02$5.47$5.07$4.49$4.27$3.42$3.11$2.93$1.75$1.65
Operating cash flow$2.9B$3.0B$2.4B$1.9B$2.2B$2.1B$1.8B$1.8B$1.3B$713.0M
Free cash flow$2.3B$2.3B$1.6B$1.3B$1.7B$1.7B$1.3B$1.5B$1.1B$497.0M
Cash & equivalents$2.5B$2.0B$2.0B$3.6B$3.5B$3.6B$1.9B$1.6B$1.6B$727.0M
Inventory$2.5B$2.3B$2.6B$2.3B$1.9B$1.6B$1.4B$1.4B$1.4B$1.5B
Total assets$15.5B$14.2B$14.3B$14.9B$13.9B$13.6B$11.5B$10.8B$8.6B$7.6B
Total liabilities$12.1B$9.5B$9.3B$10.5B$9.4B$9.8B$8.8B$8.6B$6.8B$6.2B
Shareholders' equity$3.4B$4.8B$5.0B$4.4B$4.5B$3.8B$2.7B$2.2B$1.8B$1.5B

Growth · year-over-year · Revenue CAGR 7.6%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+2.3%+8.3%+5.7%+3.9%+16.5%+6.6%+7.5%+9.8%+8.6%+2.6%
Net income growth+7.5%+6.1%+10.9%+3.8%+24.4%+9.2%+5.0%+65.3%+5.2%+142.2%
EPS growth+10.1%+7.9%+12.9%+5.2%+24.9%+10.0%+6.1%+67.4%+6.1%+142.6%
Free cash flow growth-0.7%+41.8%+22.2%-23.6%+3.8%+25.3%-8.1%+29.4%+125.8%+13.0%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.